Lateral Flow Assays Market Projected to Reach $12.1 Billion by 2030
Market growth driven by expanding clinical applications and regulatory innovation, with kits and reagents dominating product segments.
Market growth driven by expanding clinical applications and regulatory innovation, with kits and reagents dominating product segments.
Mitigating biotin interference on immunoassays is a critical factor to ensure appropriate diagnosis and treatment.
The January/February 2025 Tech Guide in Clinical Lab Products (CLP) showcases a variety of products from nine leading laboratory providers.
Beckman Coulter expanded the menu of assays for its DxI 9000 Access Immunoassay Analyzer with the recent CE marking of hepatitis tests.
The TaqPath COVID-19 Diagnostic PCR Kit enables labs to adopt a validated in vitro diagnostic workflow for SARS-CoV-2 detection.
Having high-quality assays, molecular controls, and automated workflow solutions are critical in...